Concepedia

Miyuki Morikawa

MM

Statistics

Publications

8

Citations

1K

H-Index

8

Active since

2016

Affiliations

Kindai University(Current)

Alexion Pharmaceuticals (United States)

Fondazione IRCCS Istituto Neurologico Carlo Besta

National Hospital Organization Hanamaki Hospital

Stanford University

Miyuki Morikawa is an author at Kindai University specializing in medicine, neuroimmunology, and immunology.

Top concepts

Publications per year

2016–2020

8

Publications

8

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

, , +3

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 74 citations · Full text

Bickerstaff brainstem encephalitis with or without anti-GQ1b antibody

Keisuke Yoshikawa, Motoi Kuwahara, Miyuki Morikawa et al. · Neurology Neuroimmunology & Neuroinflammation · 2020 · 43 citations · Full text

Characterization of the neurological diseases associated with Mycoplasma pneumoniae infection and anti-glycolipid antibodies

Motoi Kuwahara, Makoto Samukawa, Tae Ikeda et al. · Journal of Neurology · 2016 · 42 citations

, , +11

Varied antibody reactivities and clinical relevance in anti-GQ1b antibody–related diseases

Keisuke Yoshikawa, Motoi Kuwahara, Miyuki Morikawa et al. · Neurology Neuroimmunology & Neuroinflammation · 2018 · 34 citations · Full text

1–5 of 8